• Strong revenue growth of 16% to $3b, with underlying EBIT increasing 4.7% to $515m
• Resilient underlying EBIT margin of 19.1% (excluding recent acquisitions)
• Robust Life Sciences performance fuelled by leading Environmental organic revenue growth of 9.8% and solid Food result with organic growth of 6.0%

ALS Ltd reported strong full year results, with revenue growth of 16% to $3b and underlying EBIT increasing 4.7% to $515m. The company's diversified and resilient business model delivered a resilient underlying EBIT margin of 19.1%, excluding recent acquisitions. The Minerals business maintained strong margins above 31% through the world-class hub & spoke model, client service offering, innovative high-performance methods and continued downstream diversification. The Life Sciences division saw robust performance, with leading Environmental organic revenue growth of 9.8% and solid Food result with organic growth of 6.0%. The integration of recent Life Sciences acquisitions, including Wessling and Nuvisan, is progressing ahead of plan. ALS continues to prioritize innovation and the adoption of technology solutions throughout all business streams to optimize operations and customer experience. The company generated strong FY25 cash conversion of $591m, representing 95% of underlying EBITDA.